全基因组关联研究更新再检视抗幽门螺杆菌IgG滴度的Toll样受体1位点
在低胃癌发病率欧洲人群的更新全基因组关联研究荟萃分析中,抗幽门螺杆菌IgG滴度与4p14上TLR1/6/10位点的关联(rs12233670)呈现高异质性且未能重复。根除治疗后2-4年内抗幽门螺杆菌IgG滴度下降,且TLR1/6/10变异影响单核细胞和中性粒细胞的TLR1表面表达及细胞因子产生。
要点
- 抗幽门螺杆菌IgG滴度与TLR1/6/10位点的关联未能在各队列中重复。
- 根除治疗后2-4年内抗幽门螺杆菌IgG滴度下降(P=0.004)。
- TLR1/6/10变异影响单核细胞和中性粒细胞TLR1表面表达及细胞因子产生。
核心结论
- 抗幽门螺杆菌IgG滴度与TLR1/6/10位点的关联未能在各队列中重复,可能由于抗幽门螺杆菌IgG滴度依赖于治疗、清除和抗体衰减。
- 幽门螺杆菌介导的免疫细胞活化部分通过TLR1信号传导,而TLR1信号传导受遗传变异影响。
研究设计与样本
- 二分类全基因组关联研究(最高25%抗幽门螺杆菌IgG滴度个体 vs 其余75%)纳入发现样本n=15,685和重复样本n=9,676,均为欧洲血统。
- 对根除幽门螺杆菌的受试者(n=132)和癌前胃病变监测患者(n=107)进行血清学纵向分析。
- 在健康受试者(n=26)的白细胞亚群中测量TLR1/6/10表面表达、TLR1 mRNA和细胞因子水平,受试者已对TLR1/6/10变异进行基因分型。
主要发现
- TLR1/6/10位点与抗幽门螺杆菌IgG滴度的关联(rs12233670;β=-0.267±SE 0.034;P=4.42×10^-15)呈现高异质性且未能重复。
- 根除治疗后2-4年内抗幽门螺杆菌IgG滴度下降(P=0.004),癌前胃病变患者中滴度随时间下降(P<0.001)。
- TLR1/6/10位点变异影响TLR1介导的细胞因子产生以及单核细胞(P=0.016)和中性粒细胞(P=0.030)的TLR1表面表达,但不影响mRNA水平。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: A genome-wide significant association between anti-Helicobacter pylori (H pylori) IgG titers and Toll-like receptor (TLR1/6/10) locus on 4p14 was demonstrated for individuals of European ancestry, but not uniformly replicated. We re-investigated this association in an updated genome-wide association study (GWAS) meta-analysis for populations with low gastric cancer incidence, address potential causes of cohort heterogeneity, and explore functional implications of genetic variation at the TLR1/6/10 locus. METHODS: The dichotomous GWAS (25% individuals exhibiting highest anti-H pylori IgG titers vs remaining 75%) included discovery and replication sampls of, respectively, n = 15,685 and n = 9676, all of European ancestry. Longitudinal analysis of serologic data was performed on H pylori-eradicated subjects (n = 132) and patients under surveillance for premalignant gastric lesions (n = 107). TLR1/6/10 surface expression, TLR1 mRNA, and cytokine levels were measured in leukocyte subsets of healthy subjects (n = 26) genotyped for TLR1/6/10 variants. RESULTS: The association of the TLR1/6/10 locus with anti-H pylori IgG titers (rs12233670; β = -0.267 ± SE 0.034; P = 4.42 × 10-15) presented with high heterogeneity and failed replication. Anti-H pylori IgG titers declined within 2-4 years after eradication treatment (P = 0.004), and decreased over time in patients with premalignant gastric lesions (P < 0.001). Variation at the TLR1/6/10 locus affected TLR1-mediated cytokine production and TLR1 surface expression on monocytes (P = 0.016) and neutrophils (P = 0.030), but not mRNA levels. CONCLUSIONS: The association between anti-H pylori IgG titers and TLR1/6/10 locus was not replicated across cohorts, possibly owing to dependency of anti-H pylori IgG titers on therapy, clearance, and antibody decay. H pylori-mediated immune cell activation is partly mediated via TLR1 signaling, which in turn is affected by genetic variation.
引用
- Lam SY, Mommersteeg MC, Yu B, et al. Toll-Like Receptor 1 Locus Re-examined in a Genome-Wide Association Study Update on Anti-Helicobacter pylori IgG Titers. Gastroenterology. 2022. PMID: 35031300. doi:10.1053/j.gastro.2022.01.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。